Patents Assigned to OMNI BIO PHARMACEUTICAL, INC.
  • Publication number: 20140348859
    Abstract: Compositions of and methods for making and using alpha-1 antitrypsin (AAT) fusion molecules or peptide derivatives thereof are disclosed. The compositions and methods relate to generating an AAT fusion molecule of use in pharmaceutically acceptable compositions to treat a subject in need of AAT therapy or treatment. Compositions and methods disclosed herein concern linking AAT or derivative thereof to an immune fragment.
    Type: Application
    Filed: January 10, 2013
    Publication date: November 27, 2014
    Applicants: KONKUK UNIVERSITY, OMNI BIO PHARMACEUTICAL, INC., THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Soohyun Kim, Charles A. Dinarello, James D. Crapo
  • Publication number: 20140107042
    Abstract: Embodiments herein report methods and compositions for treating or preventing adverse effects of radiation therapies. In certain embodiments, compositions and methods relate to reducing or inhibiting damage due to acute, periodic or chronic radiation exposure.
    Type: Application
    Filed: March 9, 2012
    Publication date: April 17, 2014
    Applicant: OMNI BIO PHARMACEUTICAL, INC.
    Inventors: James D. Crapo, A. Mario Q. Marcondes, H. Joachim Deeg